Bulk-Forming Laxative
Pregnancy: Compatible — first-line bulk-forming laxative in pregnancy; not absorbed.
Ispaghula Husk
Brand names: Fybogel, Metamucil, Regulan
Adult dose
Dose: 1 sachet (3.5g) dissolved in 150mL water, taken once to three times daily.
Route: Oral
Frequency: Once to three times daily (after meals)
Max: 3 sachets/day (10.5g/day)
Mix sachet in full glass of water (≥150mL) and drink immediately — do not take dry (risk of oesophageal obstruction). Onset 12–24 hours (bulk-forming). NICE CG61: first-line for IBS with predominant constipation. Also lowers cholesterol (reduces LDL by ~5–7%).
Paediatric dose
Route: Oral
Frequency: Twice daily
Max: 1 sachet per dose
BNF for Children: 6–11 years: ½ sachet (1.75g) twice daily; 12–17 years: 1 sachet twice daily. Must be taken with full glass of water. Source: BNF for Children 2024.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
No dose adjustment required.
Clinical pearls
- NICE CG61 (IBS): ispaghula husk is first-line dietary supplement for IBS-C (constipation predominant). Advise patient bloating may worsen initially — persevere for 4 weeks.
- Must be taken with at least 150mL water — risk of oesophageal or intestinal obstruction if taken dry. Never give to bedridden patients who cannot maintain upright position.
- Cholesterol lowering: soluble fibre reduces LDL by ~5–7% — useful add-on in hypercholesterolaemia.
- Fybogel sachets are orange-flavoured or unflavoured — check patient preference for adherence.
Contraindications
- Intestinal obstruction or stricture
- Difficulty swallowing (risk of oesophageal obstruction if taken dry or without adequate water)
- Faecal impaction
Side effects
- Flatulence and bloating (especially in first 1–2 weeks — usually settles)
- Abdominal distension
- Oesophageal obstruction (if taken without adequate fluid)
- Allergic reactions (rare — cross-reactivity with psyllium plant allergy)
Interactions
- Multiple oral drugs: reduces absorption if taken simultaneously — separate by at least 1 hour
- Digoxin / warfarin / salicylates: reduced absorption — take at least 1 hour apart
Monitoring
- Stool consistency and frequency
- Adequate fluid intake
Reference: BNFc; BNF 90; NICE CG61 Irritable Bowel Syndrome. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021